S

Shukra Pharmaceuticals Limited

SHUKRAPHAR
Market snapshot · 2026-08-10 19:04 UTC

40.08

+₹1.04 (+2.66%)

MARKET CAP

₹1.76K Cr

STOCK P/E

80.2x

52W HIGH

₹65.26

52W LOW

₹17.06

BOOK VALUE

₹2.09

EPS

₹0.50

ROE

28.89%

SECTOR

Health Care

DEBT/EQUITY

5.59

VOLUME

15.08L

P/B RATIO

19.14x

PEG RATIO

Sector

Health Care

Themes

Pharmaceuticals
D
Dividend
₹59.06₹48.78₹38.50₹28.22₹17.94VolumeDAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 183.2% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.39). Confidence: 50%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Overvalued

5Y Average

24.70

Current

78.08

Overvalued

62.50

Undervalued

13.19

EV/EBITDA
Strongly Overvalued

5Y Average

15.89

Current

51.58

Overvalued

28.44

Undervalued

1.37

P/S
Strongly Overvalued

5Y Average

9.53

Current

30.94

Overvalued

17.06

Undervalued

0.82

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹6.00 CrMar 2026

Latest net profit

₹-2.00 CrMar 2026

Latest EPS

₹-0.04Mar 2026

Net margin

-4.9%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-25.0%0.0%25.0%50.0%75.0%-15 Cr0.00 Cr15 Cr30 Cr45 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr10 Cr20 Cr30 Cr40 Cr₹-0₹0₹0₹0₹1
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit-2.00 Cr0.00 Cr2.00 Cr4.00 Cr6.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2025Sep 2025Mar 2026-40 Cr0.00 Cr40 Cr80 Cr120 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹6 Cr

-52.3%

Net Profit

₹-2 Cr

-131.9%

EBITDA

₹2 Cr

-81.2%

EPS

₹-0.04

-133.3%
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales1356396
Expenses757137
Operating Profit61-126-0
OPM %48.05%9.86%-20.91%67.2%-4.86%
Other Income11211
Interest00000
Depreciation11111
Profit before tax810270
Tax %28.85%25.02%-1098.59%24.1%549.88%
Net Profit51220-2
EPS in Rs0.120.020.050.47-0.04

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Loading shareholding pattern...